SCHEMBL30179415

SCHEMBL30179415

O=C(O)CNC(=O)CCn1cccnc1=O

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PSMB1 P20618 1/20 0.44
▸ PSMB5 P28074 2/20 0.40
▸ THRB P10828 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ EGLN2 Q96KS0 1/20 0.38
▸ FTO Q9C0B1 1/20 0.38
▸ ESR1 P03372 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HPGD P15428 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ EGLN1 Q9GZT9 2/20 0.35
▸ LMNA P02545 1/20 0.34
▸ ITGB1 P05556 1/20 0.34
▸ ITGA5 P08648 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24843680 0.83 ESR1 (0.51) POLBESR1ALDH1A1SMN1; SMN2MAPT
SCHEMBL1155881 0.73 ALDH1A1 (0.42) POLBALDH1A1MAPTLMNAKMT2A
SCHEMBL16203677 0.67 PTGS1 (0.51) POLBALDH1A1SMN1; SMN2MAPTHPGD
SCHEMBL17077928 0.67 — —
SCHEMBL11964124 0.65 LMNA (0.38) POLBALDH1A1SMN1; SMN2MAPTHPGD
SCHEMBL31309882 0.65 PTGS1 (0.49) POLBALDH1A1SMN1; SMN2MAPTHPGD
SCHEMBL24581267 0.65 PTGS1 (0.49) POLBALDH1A1SMN1; SMN2MAPTHPGD
SCHEMBL30963644 0.65 PTGS1 (0.49) POLBALDH1A1SMN1; SMN2MAPTHPGD
SCHEMBL8516519 0.64 TLR8 (0.50) POLBALDH1A1SMN1; SMN2MAPTHPGD
SCHEMBL10070297 0.63 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023278456-A2 PYRIMIDINE-COMPLIANT PEPTIDE NUCLEIC ACID COMPOSITIONS AND METHODS OF USE THEREOF NEUBASE THERAPEUTICS, INC. (US) 2023-01-05 — — WO disclosed
Send feedback